Precision Medicine in Canine Oncology: Unlocking the Potential of Small Molecule Targeted Therapy

Presentation Description / Summary: This presentation will provide a comprehensive overview of the transformative journey that has unfolded over the years, spotlighting key small molecules like palladia, masitinib, sorafenib, lapatinib, imatinib, and others. Through insightful exploration, we will uncover the profound impact of these small molecules on canine cancer care. By dissecting their mechanisms of action, we'll unveil how they selectively target specific molecular pathways, fostering a new era of personalized treatment strategies. We will showcase the application of these therapies in real-world clinical settings, detailing practices and protocols for integration into veterinary oncology practice. The presentation will peer into the future, offering a view of the untapped potential that lies ahead in small molecule targeted therapy. As the landscape of oncology continues to evolve, we will discuss ongoing research endeavors and emerging trends, illuminating the path toward more refined and effective treatments. Central to the success of these therapies is the imperative role of genetic testing. As we navigate the intricate landscape of canine cancer treatment, genetic testing emerges as a crucial tool for informed decision-making. We will emphasize the significance of genetic profiling in tailoring treatment regimens, ensuring optimal outcomes while minimizing side effects. This presentation encapsulates the dynamic synergy of science, medicine, and innovation in the realm of small molecule targeted therapy. It's an opportunity to gain unparalleled insights, explore the evolving horizons of canine oncology, and chart a course towards enhanced care and improved quality of life for companion dogs.

Learner Outcomes: The attendees of this lecture will gain a comprehensive understanding of the key small molecules, including palladia, masitinib, sorafenib, lapatinib, imatinib, and others, and their mechanisms of action in targeting specific molecular pathways within canine cancer cells. Also, acquire practical knowledge about the effective integration of small molecule targeted therapy into veterinary oncology practice. Learn how to tailor treatment regimens and make informed decisions based on genetic profiling. The audience will understand the importance of precision medicine in tailoring therapies to individual patients. Learn how to navigate genetic testing to select the most suitable small molecule therapies, how to combine to other therapies (chemo and radiation), optimizing therapeutic outcomes while minimizing adverse effects. Walk away with practical insights to improve patient care and elevate the quality of life for canine companions diagnosed with cancer. Understand how small molecule targeted therapy can contribute to more personalized, effective, and tailored treatment approaches.